17 septembre 2020
4 mars 2020
Theramex, the global specialty pharmaceutical company dedicated to women’s health, is pleased to announce the appointment of Robert Stewart as Chief Executive Officer, effective 9th March 2020. Anish Mehta has decided to step down as CEO for personal reasons, but will work with Robert to ensure a smooth transition over the coming months.
Anish has successfully completed the first phase of the carve-out of Theramex from Teva. He has created a strong foundation for the business focused on enabling women across the globe to live happier and healthier lives, with the help of Theramex products. Robert and the team will continue to build on these strong foundations in the next chapter, to drive best-in-class commercial execution, and the successful delivery of the Company’s strategic ambition to continue to serve as a lifetime partner for women, and their healthcare practitioners.
Prior to joining Theramex, Robert was formerly the CEO of Amneal, a $1.7bn global turnover pharma business with 225+ products sold in markets across the globe, and an employee base of 6,000+. He also served as Group COO of Allergan, where he garnered a wealth of experience in women’s health, aesthetics, specialty and branded generics, all of which he brings to bear in his new role at Theramex.
Fred Hassan, Chairman of Theramex said: “We are delighted to welcome Robert to Theramex, and look forward to seeing him and the team continue with our ambition of building a best-in-class women’s healthcare company focused on sustainable organic growth and strategic business development. I want to thank Anish for his exceptional work in carving out the business from Teva and building an excellent foundation for Theramex’ future growth. I wish him continued success as he starts the next chapter in his professional career.”
Robert Stewart said: “I am excited to join Theramex at such an exciting time and look forward to working alongside the incredible talent at the company to accelerate our growth and fulfilling our mission in supporting the health needs of women globally”.
Theramex is a leading, global specialty pharmaceutical company dedicated to women and their health. With a broad portfolio of innovative and established brands covering contraception, fertility, menopause and osteoporosis, we support women at every stage of their lives. Our commitment is to listen to and understand our patients, serve their needs, and offer healthcare solutions to help improve their lives. Our vision is to be a lifetime partner for women and the healthcare professionals who treat them by providing innovative, effective and safe solutions that care for and support women as they advance through each stage of their lives. For more information, visit www.theramex.com